Nawal Kassem

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024

Mary B. Daly, Tuya Pal, Kara N. Maxwell et al. · Journal of the National Comprehensive Cancer Network · 2023 · 249 citations · Full text

Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology

Rachel Hodan, Samir Gupta, Jennifer M. Weiss et al. · Journal of the National Comprehensive Cancer Network · 2024 · 69 citations

Cancer Pathology, Epidemiology Of Cancer, Genetic Epidemiology +23

BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer

Bryan P. Schneider, Guanglong Jiang, Tarah J. Ballinger et al. · Journal of Clinical Oncology · 2021 · 49 citations

Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103.

B. P. Schneider, L. Li, Kurt W. Miller et al. · Journal of Clinical Oncology · 2011 · 44 citations

Neurogenomics, Genetics, Cancer Management +29

Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing

Milan Radovich, Susan E. Clare, Rutuja Atale et al. · Breast Cancer Research and Treatment · 2013 · 36 citations · Full text

Breast Oncology, Triple-negative Breast Cancers, Tumor Heterogeneity +10